Literature DB >> 28002096

Duloxetine as an Analgesic Reduces Opioid Consumption After Spine Surgery: A Randomized, Double-Blind, Controlled Study.

Antonio Bedin1, Rafael A Caldart Bedin, Joaquim E Vieira, Hazem A Ashmawi.   

Abstract

OBJECTIVES: Multimodal analgesia is widely advocated for the control of perioperative pain in an effort to reduce the use of opioid. Duloxetine is a selective inhibitor of serotonin and norepinephrine reuptake with efficacy for chronic pain conditions. The primary objective of this study was to evaluate the efficacy of two 60 mg oral doses of duloxetine in terms of fentanyl consumption during the postoperative period in patients undergoing elective spine surgery.
MATERIALS AND METHODS: This study was prospective, double-blind, randomized, and placebo controlled. Patients received either 60 mg duloxetine or an identical placebo 1 hour before surgery and again the following morning. The study participants were allocated into 2 groups: Group C (control) participants received the placebo and Group D (duloxetine) participants received 60 mg duloxetine. The total consumption of fentanyl 48 hours after surgery was measured. Secondary end points were pain scores and the presence or absence of adverse effects, such as headache, nausea, vomiting, itching, dizziness, and drowsiness.
RESULTS: Demographic characteristics did not differ between groups. There was a significant difference in fentanyl consumption in the first 24 hours between Groups C and D (mean difference, 223.11±39.32 µg; P<0.001). Fentanyl consumption also differed between Groups C and D after 48 hours (mean difference, 179.35±32.55 µg; P<0.000). The pain scores over 48 hours did not significantly differ between groups. The incidence of side-effects was similar in both groups. DISCUSSION: Duloxetine was effective as an adjunct for postoperative analgesia and reduced opioid consumption.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28002096     DOI: 10.1097/AJP.0000000000000471

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

Review 1.  Duloxetine for the reduction of opioid use in elective orthopedic surgery: a systematic review and meta-analysis.

Authors:  Mark W Branton; Thomas J Hopkins; Eric C Nemec
Journal:  Int J Clin Pharm       Date:  2021-01-18

Review 2.  The rising tide of opioid use and abuse: the role of the anesthesiologist.

Authors:  Elena J Koepke; Erin L Manning; Timothy E Miller; Arun Ganesh; David G A Williams; Michael W Manning
Journal:  Perioper Med (Lond)       Date:  2018-07-03

Review 3.  Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder.

Authors:  Maria Rosaria Anna Muscatello; Rocco A Zoccali; Gianluca Pandolfo; Paolo Mangano; Simona Lorusso; Clemente Cedro; Fortunato Battaglia; Edoardo Spina; Antonio Bruno
Journal:  Front Psychiatry       Date:  2019-10-25       Impact factor: 4.157

Review 4.  Management of Postoperative Pain in Patients Following Spine Surgery: A Narrative Review.

Authors:  Nitin K Prabhakar; Andrea L Chadwick; Chinwe Nwaneshiudu; Anuj Aggarwal; Vafi Salmasi; Theresa R Lii; Jennifer M Hah
Journal:  Int J Gen Med       Date:  2022-05-02

5.  Effect of Preoperative Duloxetine on Opioid Consumption in Women Undergoing Abdominal Hysterectomy: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors:  Ehsan Bastanhagh; Fahime Zamiri; Saghar Samimi Sadeh; Khadijeh Adabi; Pejman Pourfakhr
Journal:  Anesth Pain Med       Date:  2020-08-22

6.  Perioperative Duloxetine and Etoricoxibto improve postoperative pain after lumbar Laminectomy: a randomized, double-blind, controlled study.

Authors:  Josef Zekry Attia; Haidy Salah Mansour
Journal:  BMC Anesthesiol       Date:  2017-12-02       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.